Profile data is unavailable for this security.
About the company
Renascience Inc is mainly engaged in the development and sale of pharmaceuticals and medical devices. The company is engaged in the research and development of various modalities (pharmaceuticals, medical devices, artificial intelligence (AI) solutions) to solve problems in the medical field, in collaboration with physicians. The Company is engaged in the development of drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The Company is also engaged in the solve of other medical issues such as diseases of women and children, and COVID-19 infection.
- Revenue in JPY (TTM)106.94m
- Net income in JPY-258.99m
- Incorporated2000
- Employees3.00
- LocationRenascience IncNo.401Kyodo Bldg., 2-3-6, Nihombashi Hon-choSENDAI-SHI 980-8575JapanJPN
- Phone+81 227275070
- Fax+81 362620973
- Websitehttps://www.renascience.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellSeed Inc | 83.68m | -1.10bn | 12.98bn | 38.00 | -- | 9.84 | -- | 155.06 | -31.83 | -31.83 | 2.41 | 35.67 | 0.0409 | 0.6561 | 3.81 | -- | -54.00 | -46.88 | -59.08 | -50.95 | 51.09 | 53.64 | -1,319.46 | -593.85 | 5.81 | -- | 0.0949 | -- | -56.71 | -15.95 | -28.41 | -- | 21.04 | -- |
| Stella Pharma Corp | 968.76m | -279.32m | 13.24bn | 43.00 | -- | 4.91 | -- | 13.67 | -8.21 | -8.21 | 28.47 | 79.22 | 0.1966 | 0.0944 | 2.91 | 22,529,260.00 | -5.67 | -16.41 | -5.96 | -18.19 | 87.88 | 87.03 | -28.83 | -176.16 | 13.81 | -45.69 | 0.226 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.40bn | 923.00m | 15.60bn | 214.00 | 16.76 | 1.82 | 13.12 | 2.44 | 18.37 | 18.37 | 127.34 | 169.51 | 0.5080 | 1.77 | 2.62 | -- | 7.34 | -18.99 | 9.32 | -24.04 | 54.42 | 40.20 | 14.44 | -46.31 | 2.72 | -- | 0.0874 | -- | 1.67 | -- | 2.78 | -- | -- | -- |
| ReproCell Inc | 2.52bn | -324.61m | 16.87bn | 99.00 | -- | 1.92 | -- | 6.70 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 16.90bn | 58.00 | 46.43 | 9.59 | 44.20 | 16.38 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.25bn | 17.58bn | 14.00 | -- | 7.39 | -- | -- | -64.11 | -64.11 | 0.00 | 120.62 | 0.00 | -- | -- | 0.00 | -44.48 | -57.04 | -46.19 | -62.13 | -- | -- | -- | -4,587.85 | -- | -566.18 | 0.00 | -- | -- | -- | 4.27 | -- | -- | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 18.88bn | 648.00 | 7.52 | 0.5509 | 6.67 | 0.0525 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| StemRIM Inc | 0.00 | -1.90bn | 19.18bn | 45.00 | -- | 2.79 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 20.71bn | 1.42k | 9.29 | 0.7507 | 4.50 | 0.3301 | 54.22 | 54.22 | 1,555.72 | 671.41 | 0.8961 | 3.62 | 2.88 | -- | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.01bn | 22.87bn | 1.34k | -- | 0.5962 | -- | 0.3679 | -469.00 | -469.00 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | 2.32 | 46,394,780.00 | -4.71 | 0.7682 | -9.76 | 1.29 | 26.39 | 26.94 | -6.44 | 1.05 | 0.8228 | 69.88 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Kubota Pharmaceutical Holdings Co Ltd | 21.34m | -676.25m | 23.66bn | 19.00 | -- | 13.04 | -- | 1,108.88 | -10.91 | -10.91 | 0.3341 | 15.72 | 0.0121 | 3.54 | 7.98 | -- | -38.41 | -44.81 | -42.10 | -49.35 | -14.68 | -- | -3,169.69 | -8,411.59 | 12.49 | -- | 0.0121 | -- | -21.53 | -10.80 | 49.26 | -- | -4.55 | -- |
| Renascience Inc | 106.94m | -258.99m | 24.51bn | 3.00 | -- | 9.94 | -- | 229.21 | -20.35 | -20.35 | 8.40 | 186.09 | 0.0479 | -- | 4.86 | 35,648,000.00 | -11.59 | -8.97 | -12.40 | -9.35 | 95.94 | 84.44 | -242.17 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| RaQualia Pharma Inc | 3.98bn | 273.12m | 26.30bn | 85.00 | 112.75 | 3.59 | 34.55 | 6.61 | 8.97 | 8.97 | 165.54 | 281.96 | 0.3947 | 4.35 | 3.04 | -- | 2.71 | 2.64 | 3.08 | 2.90 | 82.11 | 85.46 | 6.86 | 6.36 | 4.33 | 6.63 | 0.2962 | 0.00 | 28.07 | 29.16 | 155.17 | -- | -13.74 | -- |
Data as of Feb 20 2026. Currency figures normalised to Renascience Inc's reporting currency: Japanese Yen JPY
0.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 05 Feb 2026 | 15.20k | 0.12% |
Data from 05 Feb 2026 - 05 Feb 2026Source: FactSet Research Systems Inc.
